Inactive Instrument
RAMM Pharma Corp. Stock OTC Markets
Stocks
RAMMF
CA75150G1046
Pharmaceuticals
OTC Markets Traded| Market Cap | 1.19M 846K 744K 692K 636K 81.13M 1.21M 8.23M 3.21M 40.06M 3.18M 3.11M 138M | P/E 2024 |
-0.07x | P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 470K 333K 293K 273K 251K 31.97M 477K 3.24M 1.27M 15.78M 1.25M 1.22M 54.56M | EV / Sales 2024 |
0.13x | EV / Sales 2025 | 0.32x |
| Free-Float |
68.57% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -76.29% |
| Manager | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
CEO | Chief Executive Officer | - | 2019-09-30 |
José Roldan
DFI | Director of Finance/CFO | - | 2022-12-08 |
| Director | Title | Age | Since |
|---|---|---|---|
Jackie Burnett
BRD | Director/Board Member | - | 2019-09-30 |
Daniel Augereau
BRD | Director/Board Member | 82 | 2019-09-30 |
Eric Klein
BRD | Director/Board Member | 66 | 2019-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -76.29% | -92.33% | - | - | 846K | ||
| +1.61% | +3.90% | +51.12% | +166.36% | 1,068B | ||
| +1.29% | +7.91% | +62.70% | +55.00% | 641B | ||
| +3.13% | +3.44% | +40.52% | +75.61% | 454B | ||
| +2.25% | +10.31% | +41.29% | +36.67% | 351B | ||
| +1.62% | +4.03% | +39.92% | +44.71% | 299B | ||
| +0.59% | +3.79% | +20.17% | +17.25% | 266B | ||
| +2.73% | +3.50% | -25.66% | -36.53% | 220B | ||
| +4.25% | +7.36% | +30.50% | +66.34% | 203B | ||
| +2.49% | +2.70% | +18.38% | +74.08% | 162B | ||
| Average | -5.64% | +2.76% | +30.99% | +55.50% | 407.04B | |
| Weighted average by Cap. | +1.94% | +2.85% | +40.53% | +80.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.34M 3.08M 2.7M 2.52M 2.31M 295M 4.4M 29.93M 11.69M 146M 11.55M 11.3M 504M | 3.36M 2.38M 2.09M 1.95M 1.79M 228M 3.4M 23.16M 9.05M 113M 8.94M 8.75M 390M |
| Net income | -16.5M -11.69M -10.28M -9.57M -8.79M -1.12B -16.72M -114M -44.42M -554M -43.9M -42.95M -1.91B | -8.91M -6.31M -5.55M -5.17M -4.75M -605M -9.03M -61.41M -23.99M -299M -23.7M -23.19M -1.03B |
| Net Debt | -626K -443K -390K -363K -333K -42.52M -634K -4.31M -1.68M -21M -1.66M -1.63M -72.57M | -723K -513K -451K -420K -385K -49.17M -733K -4.99M -1.95M -24.28M -1.92M -1.88M -83.91M |
Employees
-
Sector
Pharmaceuticals
















